• Embed Doc
  • Copy Link
  • Readcast
  • Collections
  • CommentGo Back
Download
 
Celgene N-IDPS RFPRequest for Proposal
 
Proprietary and Confidential
Unauthorized distribution or reproduction prohibited.Copyright © 2009 Celgene.Copyright All rights reserved.
 
Revision 1.0 (Draft) 
Project: N-IDPSPrinted on: 6/17/09Last Saved: 10/30/2009
CONTENTS
1 Corporate Information.......................................................................32 Purpose and Scope...........................................................................42.1 EXECUTIVE SUMMARY............................................................42.2 ISSUE..................................................................................53 Instructions and Considerations..........................................................63.1 DESIGNATED POINT OF CONTACT............................................63.2 RELEVANT DATES..................................................................63.3 PUBLICITY............................................................................63.4 CELGENE CONFIDENTIAL INFORMATION...................................63.5 OWNERSHIP OF MATERIAL......................................................63.6 RESPONSE SUBMISSION........................................................63.7 DISCLAIMER.........................................................................74 Solution Overview............................................................................85 Functional Requirements...................................................................95.1 CENTRALIZED MANAGEMENT..................................................95.2 PHYSICAL REQUIREMENTS....................................................115.3 RELIABILITY AND AVAILABILITY............................................125.4 DETECTION ENGINE AND RULES............................................125.5 NETWORK AND USER INTELLIGENCE......................................145.6 IDS/IPS AUTOMATION..........................................................145.7 IT POLICY COMPLIANCE........................................................145.8 NETWORK BEHAVIOR ANALYSIS (NBA)...................................155.9 THIRD-PARTY INTEGRATION.................................................155.10 TARGET LOCATIONS AND THROUGHPUT REQUIREMENTS........16
ii
 
Revision 1.0 (Proposal) 
Project: N-IDPSPrinted on: 10/30/2009Last Saved:
10/30/2009
1 C
ORPORATE
I
NFORMATION
 
Celgene is a multinational biopharmaceutical company committed to improving the livesof patients worldwide.Celgene strives to deliver truly innovative and life-changing drugs for patients. Yourmission as a company is to build a major global biopharmaceutical corporation whilefocusing on the discovery, the development, and the commercialization of products forthe treatment of cancer and other severe, immune, inflammatory conditions.There are numerous clinical trials at major medical centers using compounds fromCelgene. Investigational compounds are being studied for patients with incurablehematological and solid tumor cancers, including multiple myeloma, myelodysplasticsyndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL),glioblastoma, and ovarian, pancreatic and prostate cancer.--
www.celgene.com
 With clear commitment to clinical accomplishment, Celgene is equally committed topatient supportas a guiding principle. Celgene believes all who can benefit from itsdiscoveries should have the opportunity to do so. Celgene puts patients first withindustry-leading programs that provide information, support and access to ourinnovative therapies.With an ethics-driven culture, Celgene has demonstrated the need and responsibility toprotect information assets, their own, their customers’, their patients’, and theirpartner/suppliers’.
Page
3
Proprietary and Confidential
Unauthorized distribution or reproduction prohibited.Copyright © 2009 Celgene. All rights reserved.
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...